As primary care physicians managing L.A. Care patients, you now have additional support for key preventive measures and chronic disease monitoring through our enhanced at-home diagnostic program.
Clinical Relevance: This program directly addresses preventive and chronic care quality measures that impact your practice performance and patient outcomes, particularly for vulnerable populations.
Below is a summary of 2023 Program Performance Data:
| Diagnostic Test | Kits Deployed | Return Rate |
|---|---|---|
| Comprehensive Diabetes Panel | 3,962 | 6% |
| Fecal Immunochemical Test (FIT) | 32,584 | 10% |
| Hemoglobin A1c | 3,269 | 6% |
| Kidney Health Panel | 7,350 | 13% |
What PCPs Need to Know:
- The program is designed with inclusivity and patient-centered care at its core.
- Each kit includes everything the patient needs to complete the test. No additional tools or appointments required.
- It helps reach patients where they are - at home or digitally.
- They have the option to complete the test using a mailed kit with a prepaid return envelope.
- Patients can securely access instructions and results through a digital portal.
- Recent deployment includes 20,000+ colorectal screening kits. (October 2024)
Practice Implementation: Consider informing patients about these kits during visits and encouraging completion when you receive notification of kit deployment to your patients.
Questions or Additional Patient Nominations: Email our Quality Improvement team.
These supplemental screening tools complement your in-office care while helping meet quality metrics for preventive screening and chronic disease monitoring.